Literature DB >> 2306733

Detection of pS2 messenger RNA in gynecological cancers.

S J Wysocki1, E Hahnel, A Masters, V Smith, A J McCartney, R Hahnel.   

Abstract

Estrogen-inducible pS2 mRNA was previously detected in human cancer cell lines the growth of which was sensitive to estrogen. In the present study, the expression of the pS2 gene was analyzed in 111 gynecological carcinomas. The pS2 message was detected in greatest abundance in 6 primary carcinomas of the ovary (6 of 29), 4 of these being mucinous cystadenocarcinomas. A secondary carcinoma of the ovary, and another of the omentum (1 of 4), also contained detectable levels of pS2 mRNA. Weak pS2 mRNA signals were occasionally observed in endometrial (2 of 55) and cervical carcinomas (2 of 33) as well. There was a poor correlation between estrogen receptor and pS2 mRNA in ovarian carcinomas.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2306733

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Detection of estradiol-induced messenger RNA (pS2) in uninvolved breast tissue from mastectomies for breast cancer.

Authors:  E Hähnel; R Joyce; G Sterrett; J Harvey; R Hähnel
Journal:  Breast Cancer Res Treat       Date:  1992-03       Impact factor: 4.872

2.  A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancer.

Authors:  B Theisinger; G Seitz; S Dooley; C Welter
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Expression of pS2 protein in breast cancer.

Authors:  G Crombach; A Ingenhorst; U J Göhring; A Scharl; W Neuhaus; V Möbus; H J Schaeffer
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

4.  Expression of pS2 in prostate cancer correlates with grade and Chromogranin A expression but not with stage.

Authors:  M Hammad Ather; Farhat Abbas; Nuzhat Faruqui; M Israr; Shahid Pervez
Journal:  BMC Urol       Date:  2004-12-10       Impact factor: 2.264

5.  Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.

Authors:  Y A Luqmani; T Campbell; S Soomro; S Shousha; M C Rio; R C Coombes
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

6.  Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.

Authors:  J A Henry; M K Bennett; N H Piggott; D L Levett; F E May; B R Westley
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.